Lightcalls.com
 

The potential of garlic (Allium sat...

The potential of garlic (Allium sativum as a cancer fighter has been known since ancient times; however, research documenting the anticancer ability of garlic did not begin until the 1930 At that time, scientists charted the proceeding of cancer in countries with varied garlic consumption. They discovered that cancer cases were least belonging to all in the countries in which a large percentage of the population ate garlic.

Since then, a confuse of research has confirmed the health benefits of this acrid yet flavorful, herb. Today, garlic is attributed with destroying cancer small cavitys and inhibiting both the initiation and promotion stages of cancer. However, garlic appears to have the strongest anti-cancer meaning when consumed regularly before the attack of cancer or when cancer confined apartment numbers are small.

Garlic arrests the activity of cancer-causing substances



Garlic precludes the activity of carcinogens (cancer-causing substances). Numerous laboratory experiments indicate that garlic interrupts tumor formation, even in the demeanor of carcinogens.

Researchers at Pennsylvania State University report that garlic diminishs by up to 66 percent the general intents of a carcinogen called N-nitroso combine Garlic is theorized to obstruct cancer by limiting the binding of the N-nitroso compromises with the DNA in liver and breast cells

The carcinogenic weights of benzo(a)pyrene -- a carcinogen lay the foundation of in cigarette smoke, charcoal-broiled meats, and air pollution -- are also keep secreted by garlic. A study published in the Journal of Nutrition investigated the consequence of garlic on chemically-induced cancers in an animal standard of breast cancer. The extensiveness of tumors was assessed on the amount of binding of the carcinogen DMBA to breast small cavity DNA. Garlic reduced DMBA-DNA bindings by the agency of about half. The researchers speculate that garlic alters the bioactivation of carcinogens, which decreases tumor formation.

Other research further supports this theory. common study found that garlic may deactivate sulfydryl enzyme which are penuryed for the replication of cancer small rooms Another study reports that garlic obviates uptake of amino acids on leukemia cells. In addition, garlic stimulates glutathione-S-transferase activity, which may inhibit carcinogen-induced tumors by means of up to 70 percent.

Garlic has also been rest to prevent cancer growth in solitary abode; squalids exposed to aflatoxin, which is a mutagenic unite that can contaminate peanuts, grains, and potatoes. Garlic obstructs cancerous mutations in rat liver small cavitys exposed to aflatoxin, and is hypothesized to afford the same protection in human solitary abode; squalids Human studies of garlic and cancer have been to a high degree promising. Epidemiological case-control studies in China and Italy point out to a greatly reduced risk of stomach cancer when the diet is rich in garlic. In fact, stomach cancer risk small quantitys by up to 40 percent in those eating large amounts of garlic and onions. A reflection of 41,000 women in Iowa ground that eating garlic at least formerly a week reduced the risk of colon cancer through 35 percent.

Garlic inhibits cancer by means of strengthening the immune system

united of the ways garlic might inhibit cancer is through strengthening the immune system. Garlic injected into cancer sites enhanced the cancer-fighting ability of white family cells and increased the production of phagocytes (cell that swallow up and digest cells harmful to the body)

With in the way that many studies documenting the anti-cancer ability of garlic, it be seens that the ancient belief of garlic as a cancer fighter has been validated. The consensus from this research is that garlic impedes and/or treats cancer in at least three ways: 1) by means of direct action on tumor confined apartment metabolism; 2) by inhibition of the initiation and promotion phases of cancer; and 3) by the agency of strengthening immune function and the body's defense against cancerous changes to cells

In addition to eating more garlic, odor-controlled garlic counterparts are helpful and are available in your local health subsistence store.

REFERENCES

Amagase, H Schaffer, EM and Milner, J.A. "Dietary ingredients Modify the Ability of Garlic to Suppres 7,12-Dimethylbenz(a)anthracene-Induced Mammary DNA Adducts," Journal of Nutrition 126:817-824 1996

Ip, C Lisk, D and Scimeca, J "Potential of cheer Modification in Cancer Prevention," Cancer Research 54(supplement): 1957-1959 1994

Lau, B Tadi, P and Tosk, J "Allium sativum (garlic) and cancer prevention," Nutrition Research 10:937-948 1990

Steinmetz, K Kushi, L Bostick, R et al. "Vegetables, Fruit, and Colon Cancer in the Iowa's Women Health Study" American Journal of Epidemiology 139:1-15 1994

COPYRIGHT 1996 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2004 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.